Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression
Chunli Gong, Huan Yang, Sumin Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 21

Showing 21 citing articles:

Oxidative Stress, Inflammation and Colorectal Cancer: An Overview
Annamária Bardelčíková, Jindřich Šoltýs, Ján Mojžíš
Antioxidants (2023) Vol. 12, Iss. 4, pp. 901-901
Open Access | Times Cited: 115
Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution
Naveen Kumar, Gautam Sethi
Cancer Letters (2023) Vol. 578, pp. 216459-216459
Closed Access | Times Cited: 22
NRF2 signaling pathway and telomere length in aging and age-related diseases
Alessandro Medoro, Luciano Saso, Giovanni Scapagnini, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 10, pp. 2597-2613
Open Access | Times Cited: 13
AICAR, an AMP-Activated Protein Kinase Activator, Ameliorates Acute Pancreatitis-Associated Liver Injury Partially Through Nrf2-Mediated Antioxidant Effects and Inhibition of NLRP3 Inflammasome Activation
Lijun Kong, Hewei Zhang, Chaosheng Lu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27
5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis
Haofan Yin, Zhijian Huang, Shiqiong Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics
Songting Shou, Ayidana Maolan, Di Zhang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO
Kanpitcha Jiramitmongkon, Pichayanoot Rotkrua, Paisan Khanchaitit, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317559-e0317559
Open Access
LINC02167 stabilizes KSR1 mRNA in an m5C-dependent manner to regulate the ERK/MAPK signaling pathway and promotes colorectal cancer metastasis
Junwen Qi, Tao Jiang, Bowen Liu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Mechanistic insights into the protective potential of ambrisentan against L-arginine induced acute pancreatitis and multiorgan damage (role of NRF2/HO-1 and TXNIP/NLRP3 pathways)
Khaled H Almutary, Marwa S. Zaghloul, Manar A. Nader, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118119-118119
Closed Access
Ctnnb1 and Keap1-Nrf2 mediating divergent heat resistance in two congeneric oysters
Jincheng Chen, Chaogang Wang, Mingyang Du, et al.
International Journal of Biological Macromolecules (2025), pp. 143183-143183
Closed Access
Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
Sally A. Fahim, Yehia A. ElZohairy, Rehab I. Moustafa
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The role of cycloastragenol at the intersection of NRF2/ARE, telomerase, and proteasome activity
Sinem Yılmaz, Erdal Bedіr, Petek Ballar
Free Radical Biology and Medicine (2022) Vol. 188, pp. 105-116
Open Access | Times Cited: 14
Role of NRF2 in Colorectal Cancer Prevention and Treatment
Jiaxiang Li, Dan Wang, Yifei Liu, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 14
Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer
Huafeng Jiang, Senjun Zhou, Gang Li
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report
Caner Ercan, Mairene Coto‐Llerena, John Gallon, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 6
Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy
Jordan D. Lewicky, Alexandrine L. Martel, Nya L. Fraleigh, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2710-2710
Open Access | Times Cited: 6
Multifunctional Molecular Hybrid for Targeted Colorectal Cancer Cells: Integrating Doxorubicin, AS1411 Aptamer, and T9/U4 ASO
Kanpitcha Jiramitmongkon, Pichayanoot Rotkrua, Paisan Khanchaitit, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase (TERT) gene expression status
A. Drobyshev, Alexander Modestov, Maria Suntsova, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Ferroptosis-related prognostic model of mantle cell lymphoma
Qianwen Gao, Xin Wang, Yue Zhang, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access
The role of Cycloastragenol at the intersection of Nrf-2/ARE, telomerase, and proteasome activity
Sinem Yılmaz, Erdal Bedіr, Petek Ballar
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
A Ferroptosis-Related Prognostic Model of Mantle Cell Lymphoma
Qianwen Gao, Xin Wang, Yue Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top